US 11878049
Mitapivat therapy and modulators of cytochrome P450
granted A61KA61K31/496A61K38/45
Quick answer
US patent 11878049 (Mitapivat therapy and modulators of cytochrome P450) held by Agios Pharmaceuticals, Inc. expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/496, A61K38/45, A61K45/06